Start Date
5-27-2021 9:00 AM
End Date
5-27-2021 5:00 PM
Description
In the US, colorectal cancer (CRC) is the third leading cause of cancer-related deaths. According to the 2018 CDC Behavioral Risk Factor Surveillance System survey, 68.8% of US adults between 50 and 75 were up to date on colorectal screening (CRCS) across all screening modalities. In light of the COVID-19 pandemic, screening has dropped even further and is still 50% below pre-pandemic levels. At Jefferson, our CRCS rate is below the national average at 55.4%. Given the importance of regular screening for CRC prevention, this is clearly inadequate. There are several barriers to completing an invasive screening modality like a colonoscopy, but FIT testing may be a more feasible option.
Our aim was to increase the colonoscopy screening rate at JHAP by 15% over a period of eight months (September-April).
Keywords
screening, colonoscopy, FIT
Included in
Improving Colon Cancer Screening Rates in an Ambulatory Resident Clinic
In the US, colorectal cancer (CRC) is the third leading cause of cancer-related deaths. According to the 2018 CDC Behavioral Risk Factor Surveillance System survey, 68.8% of US adults between 50 and 75 were up to date on colorectal screening (CRCS) across all screening modalities. In light of the COVID-19 pandemic, screening has dropped even further and is still 50% below pre-pandemic levels. At Jefferson, our CRCS rate is below the national average at 55.4%. Given the importance of regular screening for CRC prevention, this is clearly inadequate. There are several barriers to completing an invasive screening modality like a colonoscopy, but FIT testing may be a more feasible option.
Our aim was to increase the colonoscopy screening rate at JHAP by 15% over a period of eight months (September-April).
Comments
Presented at the 2021 House Staff Quality Improvement and Patient Safety Conference